MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study - Concepedia

Concepedia

Publication | Open Access

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

DOI Full Paper Access

72

Citations

20

References

2018

Year

Phil Ambery, Sebastian Klammt, Maximillian G. Posch, Marcella Petrone, Wenji Pu, Cristina M. Rondinone, Lutz Jermutus, Boaz Hirshberg

British Journal of Clinical Pharmacology

Abstract

In this single-dose, Phase 1 study in healthy subjects, the safety and pharmacokinetic profiles of MEDI0382 support once-daily dosing and further clinical development of MEDI0382.

References

	Year	Citations

Page 1